Gene set enrichment analysis (GSEA) demonstrated that Nf1/p53-deleted tumors were enriched for targets of E2F, a transcription factor downstream of the INK4A-retinoblastoma (RB1) tumor suppressor pathway (Fig. 2A). This evidence concerns the gene TP53 and neoplasm.